Latest Diabetic Nephropathy News
Sitagliptin Better for Glycemic Control in T2D With Renal Impairment
Study results indicated that sitagliptin showed greater glycemic efficacy than dapagliflozin treatment.
ADA, EASD Issue New Recommendations for T2DM
Additional focus on lifestyle management, self-management education and support emphasized
High Phosphorus Predicts Diabetic Nephropathy Progression
Highest vs lowest quartile of serum phosphorus is independently associated with a nearly 3-fold increased risk of diabetic nephropathy progression.
Cardiovascular Event Rates Vary by Kidney Failure Cause
Among US dialysis patients, cardiovascular event rates are highest in those with diabetic nephropathy and lowest among those with IgA nephropathy.
Canagliflozin Trial for T2D, CKD Halted Due to Positive Results
A clinical trial assessing canagliflozin (Invokana; Janssen) as an addition to standard-of-care in patients with chronic kidney disease (CKD) and type 2 diabetes (T2D) has been stopped early after meeting its pre-specified efficacy criteria.
Trulicity Labeling Updated to Include Data on T2D Patients With CKD
In the AWARD-7 trial, patients who received Trulicity 0.75mg or 1.5mg in combination with mealtime insulin lispro achieved similar glycemic control with weight loss vs patients who received traditional basal-bolus insulin.
Dulaglutide Assessed for Type 2 Diabetes With CKD
Dulaglutide is a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist.
Diabetic ESRD Linked to Elevated Fibrinogen
Patients with higher levels of serum fibrinogen have higher rates of progression.
More Rapid Decline in Kidney Function for Diagnosed Diabetes
Much steeper decline in adjusted mean eGFR for those with diagnosed diabetes versus those without.
Metformin Can Be Used Safely at Lower Levels of Renal Function
New study shows metformin is not associated with an increased risk of acidosis in patients with type 2 diabetes and an eGFR of 30 to 60 mL/min/1.73 m2.
Gestational Diabetes May Indicate Future Subclinical Renal Issues
Women who had gestational diabetes more likely to show increased eGFR levels many years postpartum
Novel Signal ID'd for Microalbuminuria in Europeans With T2DM
Genome-wide association study identified novel signal near GABRR1, which was not seen in Asians.
Study: ESRD Risk in Type 1 Diabetes Pts Has Declined
Relative risk of end-stage renal disease was 0.13 in those diagnosed in 1995-2011 versus 1965-1979.
SHPT Highly Prevalent Among Diabetic Nephropathy Patients
Nearly 86% of diabetic nephropathy patients from an Egyptian outpatient center had elevated iPTH levels.
End-Stage Renal Disease From Diabetes Declined in US
2000 to 2014 saw decrease in incidence of ESRD with diabetes listed as the primary cause.
Newsletter Signup
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Anemia
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetes
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Hemodialysis
- Hyperphosphatemia
- Hypertension
- Hyperuricemia
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)
- Transplantation
Renal and Urology News Articles
- Febuxostat Increases CV Event Risk Only in Established CV Disease
- CT Abdominal Aortic Calcification Score Predicts CV Event Risk
- Glucose Dysregulation Seen Years Before Diabetes Diagnosis
- Poor Experience With PCP Linked to Hospitalization in CKD
- Light Use of Topical Skin Tx Before Radiotherapy Seems Safe